- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular carcinoma
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-21
DOI
10.1038/s41572-020-00240-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Novel patient-derived preclinical models of liver cancer
- (2020) Erin Bresnahan et al. JOURNAL OF HEPATOLOGY
- mRECIST for HCC: Performance and novel refinements
- (2020) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Advances in molecular classification and precision oncology in hepatocellular carcinoma
- (2020) Sandra Rebouissou et al. JOURNAL OF HEPATOLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Natural history of NASH and HCC
- (2020) Francesco Negro LIVER INTERNATIONAL
- New predictors for immunotherapy responses sharpen our view of the tumour microenvironment
- (2020) Tullia C. Bruno NATURE
- Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
- (2020) Xiao-Song Li et al. BIOSCIENCE REPORTS
- Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference
- (2020) Josep M. Llovet et al. HEPATOLOGY
- Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC).
- (2020) Robin Kate Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
- (2020) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
- (2020) Elliot B. Tapper et al. JOURNAL OF HEPATOLOGY
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase trial
- (2020) Tae Hyun Kim et al. JOURNAL OF HEPATOLOGY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
- (2019) Chunfeng Qu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT).
- (2019) Masatoshi Kudo et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- The Intersection between Tumor Angiogenesis and Immune Suppression
- (2019) Osama E. Rahma et al. CLINICAL CANCER RESEARCH
- Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
- (2019) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
- (2019) Namiki Izumi et al. JOURNAL OF CLINICAL ONCOLOGY
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
- (2019) Robert Montal et al. BRITISH JOURNAL OF CANCER
- An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
- (2019) Agrin Moeini et al. GASTROENTEROLOGY
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores
- (2019) George N. Ioannou et al. GASTROENTEROLOGY
- Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma
- (2019) Po-Chien Shen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
- (2019) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Molecular and histological correlations in liver cancer
- (2019) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- The role of telomeres and telomerase in cirrhosis and liver cancer
- (2019) Jean-Charles Nault et al. Nature Reviews Gastroenterology & Hepatology
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- The Immunobiology of Hepatocellular Carcinoma in Humans and Mice: Basic Concepts and Therapeutic Implications
- (2019) Jiajie Hou et al. JOURNAL OF HEPATOLOGY
- Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis
- (2019) Giammauro Berardi et al. JOURNAL OF HEPATOLOGY
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
- (2019) Jens Ricke et al. JOURNAL OF HEPATOLOGY
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
- (2019) Peter R. Galle et al. LIVER INTERNATIONAL
- First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma
- (2019) Richard D Kim et al. Cancer Discovery
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
- (2019) Bettina Langhans et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The chances of hepatic resection curing hepatocellular carcinoma
- (2019) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Adaptive immunity: an emerging player in the progression of NAFLD
- (2019) Salvatore Sutti et al. Nature Reviews Gastroenterology & Hepatology
- Image-Guided Percutaneous Microwave Ablation Versus Cryoablation For Hepatocellular Carcinoma In High-Risk Locations: Intermediate-Term Results
- (2019) Jiahui Hu et al. Cancer Management and Research
- Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma
- (2019) Yong Xia et al. JAMA Oncology
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs
- (2019) Anita Paisant et al. JOURNAL OF HEPATOLOGY
- Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
- (2019) Paulo Bergerot et al. MOLECULAR CANCER THERAPEUTICS
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study
- (2018) Ian Chau et al. BRITISH JOURNAL OF CANCER
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients withRAS-mutated Hepatocellular Carcinoma
- (2018) Ho Yeong Lim et al. CLINICAL CANCER RESEARCH
- Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma
- (2018) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- A long-term experience with expansion of Milan criteria for liver transplant recipients
- (2018) Sarah Jane Commander et al. CLINICAL TRANSPLANTATION
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical states of cirrhosis and competing risks
- (2018) Gennaro D'Amico et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
- (2018) Ismail Labgaa et al. ONCOGENE
- Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis
- (2018) Xiao-Lin Xu et al. RADIOLOGY
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
- (2018) Dabin Liu et al. Science Translational Medicine
- Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests
- (2018) Gonzalo Torga et al. JAMA Oncology
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
- (2018) Roser Pinyol et al. GUT
- Impaired brain glymphatic flow in experimental hepatic encephalopathy
- (2018) Anna Hadjihambi et al. JOURNAL OF HEPATOLOGY
- Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
- (2018) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Necroptosis microenvironment directs lineage commitment in liver cancer
- (2018) Marco Seehawer et al. NATURE
- Neighbourhood deaths cause a switch in cancer subtype
- (2018) Eli Pikarsky NATURE
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Is it Time to Abandon the Milan Criteria?
- (2018) Karim J. Halazun et al. ANNALS OF SURGERY
- Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study
- (2018) JIMMY XU et al. ANTICANCER RESEARCH
- Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
- (2018) Marcus Grohmann et al. CELL
- Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
- (2018) Mark A. Febbraio et al. Cell Metabolism
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy—A Systematic Review
- (2018) Christian B. van der Pol et al. GASTROENTEROLOGY
- Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
- (2018) Joong-Won Park et al. JOURNAL OF HEPATOLOGY
- Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
- (2018) Quentin Bayard et al. Nature Communications
- Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1)
- (2018) Masaaki Hidaka et al. ANNALS OF SURGERY
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
- (2017) Fasiha Kanwal et al. GASTROENTEROLOGY
- Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
- (2017) Laura Kulik et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
- (2017) Riccardo Lencioni et al. JOURNAL OF HEPATOLOGY
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
- (2017) David J. Pinato et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
- (2017) Reem Waziry et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib
- (2017) Tim Meyer et al. LIVER INTERNATIONAL
- Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
- (2017) Shabnam Shalapour et al. NATURE
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
- (2017) Rui-hua Xu et al. NATURE MATERIALS
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
- (2017) Olivier Sutter et al. RADIOLOGY
- Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
- (2017) Alvin W. T. Ng et al. Science Translational Medicine
- Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
- (2017) Eric Letouzé et al. Nature Communications
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
- (2016) Atsushi Umemura et al. CANCER CELL
- Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
- (2016) Ana L. Gomes et al. CANCER CELL
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2016) Riad Salem et al. GASTROENTEROLOGY
- IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
- (2016) Iris Martinez-Quetglas et al. GASTROENTEROLOGY
- Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
- (2016) Mei-Hwei Chang et al. GASTROENTEROLOGY
- Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
- (2016) Jie Yu et al. GUT
- An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
- (2016) Omair Atiq et al. HEPATOLOGY
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection
- (2016) Joana Ferrer-Fàbrega et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2016) Theodore S. Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
- (2016) Daniel R. Wahl et al. JOURNAL OF CLINICAL ONCOLOGY
- Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease
- (2016) Naoshi Nishida et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
- (2016) Takashi Kokudo et al. JOURNAL OF HEPATOLOGY
- Alpha-fetoprotein and 18F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation
- (2016) Geun Hong et al. JOURNAL OF HEPATOLOGY
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
- (2016) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
- (2016) Riccardo Lencioni et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
- (2016) Chi Ma et al. NATURE
- Effect of HCV clearance with direct-acting antiviral agents on HCC
- (2016) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
- (2016) Davide Citterio et al. JAMA Surgery
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Recurrence of Hepatocellular Cancer After Resection
- (2015) Parissa Tabrizian et al. ANNALS OF SURGERY
- Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
- (2015) Chi-Ping Day et al. CELL
- Global Epidemiology of Hepatocellular Carcinoma
- (2015) Katherine A. McGlynn et al. Clinics in Liver Disease
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
- (2015) Marta Garnelo et al. GUT
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- The role of hepatic resection in the treatment of hepatocellular cancer
- (2015) Sasan Roayaie et al. HEPATOLOGY
- Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
- (2015) Jean-Claude Trinchet et al. HEPATOLOGY
- Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
- (2015) Chunping Wang et al. HEPATOLOGY
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiofrequency ablationversuslaser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
- (2015) Giovan Giuseppe Di Costanzo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
- (2015) Luca Viganò et al. JOURNAL OF HEPATOLOGY
- Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
- (2015) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
- (2015) Oriana Miltiadous et al. JOURNAL OF HEPATOLOGY
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis
- (2015) Rex G. Cheng et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
- (2015) Stephan Buch et al. NATURE GENETICS
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
- (2015) Jean-Charles Nault et al. NATURE GENETICS
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
- (2015) Shlomi Finkin et al. NATURE IMMUNOLOGY
- Image-guided ablation of primary liver and renal tumours
- (2015) David J. Breen et al. Nature Reviews Clinical Oncology
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
- (2015) M. Hagel et al. Cancer Discovery
- Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
- (2015) Bruno Vincenzi et al. PLoS One
- ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
- (2014) Hayato Nakagawa et al. CANCER CELL
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
- (2014) Krishna S. Tummala et al. CANCER CELL
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- (2014) Masatoshi Kudo et al. HEPATOLOGY
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
- (2014) Lei Yin et al. JOURNAL OF HEPATOLOGY
- In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
- (2014) Ramona Rudalska et al. NATURE MEDICINE
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
- (2014) E. Horwitz et al. Cancer Discovery
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
- (2013) Tania M Welzel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis
- (2013) Peter Jepsen et al. ANNALS OF INTERNAL MEDICINE
- Screening for Liver Cancer: The Rush to Judgment
- (2013) Frank A. Lederle ANNALS OF INTERNAL MEDICINE
- Resection of Hepatocellular Carcinoma with Macroscopic Vascular Invasion
- (2013) Sasan Roayaie et al. ANNALS OF SURGICAL ONCOLOGY
- New Data Supporting Modified RECIST (mRECIST) for Hepatocellular Carcinoma
- (2013) R. Lencioni CLINICAL CANCER RESEARCH
- Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
- (2013) Francesca Bravi et al. Clinical Gastroenterology and Hepatology
- Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis
- (2013) Yujin Hoshida et al. GASTROENTEROLOGY
- Immunodominance and functional alterations of tumor-associated antigen-specific CD8+T-cell responses in hepatocellular carcinoma
- (2013) Tobias Flecken et al. HEPATOLOGY
- Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
- (2013) Jianhua Yin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
- (2013) Alexis Bujold et al. JOURNAL OF CLINICAL ONCOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Actual 10-year survival following hepatectomy for hepatocellular carcinoma
- (2013) Bernardo Franssen et al. HPB
- Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort†
- (2012) L. M. Kulik et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Resection of Hepatocellular Carcinoma Without Cirrhosis
- (2012) Brian Shrager et al. ANNALS OF SURGERY
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
- (2012) A. Lachenmayer et al. CLINICAL CANCER RESEARCH
- Predictive in vivo animal models and translation to clinical trials
- (2012) Natalie Cook et al. DRUG DISCOVERY TODAY
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
- (2012) Carlo Schneider et al. GUT
- Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
- (2012) Sasan Roayaie et al. HEPATOLOGY
- Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
- (2012) Vincenzo Mazzaferro et al. HEPATOLOGY
- Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
- (2012) Zhen-Wei Peng et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
- (2012) Marta Burrel et al. JOURNAL OF HEPATOLOGY
- The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma
- (2012) Momar Diouf et al. JOURNAL OF HEPATOLOGY
- Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
- (2012) Chih-Wen Lin et al. JOURNAL OF HEPATOLOGY
- Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
- (2012) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
- (2011) Jean-Claude Trinchet et al. HEPATOLOGY
- Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?
- (2011) Hossein Poustchi et al. HEPATOLOGY
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
- (2011) Tae-Won Kang et al. NATURE
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Health-Related Quality of Life in Patients With Hepatocellular Carcinoma: A Systematic Review
- (2010) Sheng–Yu Fan et al. Clinical Gastroenterology and Hepatology
- Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival
- (2010) Philip Hilgard et al. HEPATOLOGY
- Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis
- (2010) Bin Wang et al. JOURNAL OF HEPATOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- The Liver as a Lymphoid Organ
- (2009) Ian Nicholas Crispe Annual Review of Immunology
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
- (2009) Riad Salem et al. GASTROENTEROLOGY
- Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
- (2009) Yuan-Chin Amy Lee et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial
- (2009) Takuji Okusaka et al. JOURNAL OF HEPATOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
- (2008) M. Ravaioli et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
- (2008) Karin L. Andersson et al. Clinical Gastroenterology and Hepatology
- Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
- (2008) Takeaki Ishizawa et al. GASTROENTEROLOGY
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2008) Regina V. Tse et al. JOURNAL OF CLINICAL ONCOLOGY
- Experimental models of hepatocellular carcinoma
- (2008) Philippa Newell et al. JOURNAL OF HEPATOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started